4ETK image
Deposition Date 2012-04-24
Release Date 2012-06-13
Last Version Date 2024-11-06
Entry Detail
PDB ID:
4ETK
Keywords:
Title:
Crystal Structure of E6A/L130D/A155H variant of de novo designed serine hydrolase, Northeast Structural Genomics Consortium (NESG) Target OR186
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.70 Å
R-Value Free:
0.25
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:De novo designed serine hydrolase
Mutations:E6A, L130D, A155H
Chain IDs:A, B
Chain Length:167
Number of Molecules:2
Biological Source:artificial gene
Primary Citation
Design of activated serine-containing catalytic triads with atomic-level accuracy.
Nat.Chem.Biol. 10 386 391 (2014)
PMID: 24705591 DOI: 10.1038/nchembio.1498

Abstact

A challenge in the computational design of enzymes is that multiple properties, including substrate binding, transition state stabilization and product release, must be simultaneously optimized, and this has limited the absolute activity of successful designs. Here, we focus on a single critical property of many enzymes: the nucleophilicity of an active site residue that initiates catalysis. We design proteins with idealized serine-containing catalytic triads and assess their nucleophilicity directly in native biological systems using activity-based organophosphate probes. Crystal structures of the most successful designs show unprecedented agreement with computational models, including extensive hydrogen bonding networks between the catalytic triad (or quartet) residues, and mutagenesis experiments demonstrate that these networks are critical for serine activation and organophosphate reactivity. Following optimization by yeast display, the designs react with organophosphate probes at rates comparable to natural serine hydrolases. Co-crystal structures with diisopropyl fluorophosphate bound to the serine nucleophile suggest that the designs could provide the basis for a new class of organophosphate capture agents.

Legend

Protein

Chemical

Disease

Primary Citation of related structures